Patients with autoimmune disorders are at an increased risk of venous thromboembolism (VTE), but this association has not been consistently evaluated. We used the RIETE (Registro Informatizado Enfermedad Trombo Embólica) database to compare the rates of VTE recurrences, major bleeding, and death during the course of anticoagulation, according to the presence or absence of autoimmune disorders. Of 71 625 patients with VTE recruited in February 2018, 1800 (2.5%) had autoimmune disorders. Median duration of anticoagulant therapy was slightly longer in patients with autoimmune disorders (median, 190 vs 182 days; P = .001). On multivariable analysis, patients with autoimmune disorders had a similar risk of VTE recurrences (hazard ratio [HR]: 0.9...
BACKGROUND: Venous thromboembolism (VTE) is a common complication during and after a hospital admiss...
Autoimmune diseases are not infrequently associated with arterial or venous thrombotic events. Chron...
International audienceThrombotic manifestations are a hallmark of many auto-immune diseases (AID), s...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
BACKGROUND: Some autoimmune disorders have been linked to venous thromboembolism. We examined whethe...
Venous thromboembolism (VTE) is major health problem and is sometimes complicated by lethal pulmonar...
Previous research has suggested autoimmune diseases are risk factors for developing venous thromboem...
International audienceObjectives: Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaem...
Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) are associated with syst...
Introducción: los pacientes con Enfermedades Autoinmunes Sistémicas (EAS) tienen alto riesgo de desa...
BACKGROUND: Venous thromboembolism (VTE) is a common complication during and after a hospital admiss...
Autoimmune diseases are not infrequently associated with arterial or venous thrombotic events. Chron...
International audienceThrombotic manifestations are a hallmark of many auto-immune diseases (AID), s...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data o...
Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE) in autoi...
BACKGROUND: Some autoimmune disorders have been linked to venous thromboembolism. We examined whethe...
Venous thromboembolism (VTE) is major health problem and is sometimes complicated by lethal pulmonar...
Previous research has suggested autoimmune diseases are risk factors for developing venous thromboem...
International audienceObjectives: Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaem...
Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) are associated with syst...
Introducción: los pacientes con Enfermedades Autoinmunes Sistémicas (EAS) tienen alto riesgo de desa...
BACKGROUND: Venous thromboembolism (VTE) is a common complication during and after a hospital admiss...
Autoimmune diseases are not infrequently associated with arterial or venous thrombotic events. Chron...
International audienceThrombotic manifestations are a hallmark of many auto-immune diseases (AID), s...